Insmed | INSM - Ebitda





Ebitda Cambiamento Data
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
DBV Technologies USD -45.9M 12.42M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -148.3M 165.88M 2026-03
Novartis USD 5.41B 431M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06